New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes-Reference-Cited by-同舟云学术

New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes

Published:2018-03-08 Issue:5 Volume:36 Page:613-624
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Varnava Alice^ORCID,Bracchi Robert,Samuels Karen,Hughes Dyfrig A.^ORCID,Routledge Philip A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s40273-018-0632-7/fulltext.html

Reference57 articles.

1. Welsh Government. Health statistics Wales 2016. http://gov.wales/docs/statistics/2017/170131-health-statistics-wales-2016-summary-en.pdf . Accessed Mar 2017.

2. Stats Wales. Economic output—gross value added (GVA) and GVA per head (HI) 2015. 2016. https://statswales.gov.wales/Catalogue/Sustainable-Development/Sustainable-Development-Indicators/gva-by-measure-welsheconomicregion-year . Accessed Mar 2017.

3. Welsh Government. Prescriptions dispensed in the community 2015. 2015. http://gov.wales/docs/statistics/2016/160518-prescriptions-dispensed-community-2015-en.pdf . Accessed Mar 2017.

4. Roberts A, Charlesworth A. A decade of austerity in Wales? The funding pressures facing the NHS in Wales to 2025/26. 2014. https://www.nuffieldtrust.org.uk/research/a-decade-of-austerity-in-wales-the-funding-pressures-facing-the-nhs-in-wales-to-2025-26 . Accessed Mar 2017.

5. All Wales Medicines Strategy Group. About AWMSG. http://www.awmsg.org/awmsg_about_us.html . Accessed Oct 2017.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social care data in the UK; current landscape, challenges, and future recommendations;Expert Review of Pharmacoeconomics & Outcomes Research;2023-11-21

2. Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales;Orphanet Journal of Rare Diseases;2023-11-01

3. Reimbursement decision-making system in Poland systematically compared to other countries;Frontiers in Pharmacology;2023-10-13

4. HTA decision-making for drugs for rare diseases: comparison of processes across countries;Orphanet Journal of Rare Diseases;2022-07-08

5. Promoting innovation while controlling cost: The UK's approach to health technology assessment;Health Policy;2022-03